Maternal Health, Pregnancy and Offspring Factors, and Maternal Thyroid Cancer Risk: A Nordic Population-Based Registry Study.


Journal

American journal of epidemiology
ISSN: 1476-6256
Titre abrégé: Am J Epidemiol
Pays: United States
ID NLM: 7910653

Informations de publication

Date de publication:
06 01 2023
Historique:
received: 31 03 2022
revised: 09 09 2022
accepted: 14 09 2022
pubmed: 22 9 2022
medline: 11 1 2023
entrez: 21 9 2022
Statut: ppublish

Résumé

Thyroid cancer incidence is higher in women than men, especially during the reproductive years, for reasons that remain poorly understood. Using population-based registry data from 4 Nordic countries through 2015, we examined associations of perinatal characteristics with risk of maternal thyroid cancer. Cases were women diagnosed with thyroid cancer ≥2 years after last birth (n = 7,425, 83% papillary). Cases were matched to controls (n = 67,903) by mother's birth year, country, and county of residence. Odds ratios (ORs) were estimated using conditional logistic regression models adjusting for parity. Older age at first pregnancy, postpartum hemorrhage (OR = 1.18, 95% (confidence interval) CI: 1.08, 1.29), and benign thyroid conditions (ORs ranging from 1.64 for hypothyroidism to 10.35 for thyroid neoplasms) were associated with increased thyroid cancer risk, as were higher offspring birth weight (per 1-kg increase, OR = 1.17, 95% CI: 1.12, 1.22) and higher likelihood of offspring being large for gestational age (OR = 1.26, 95% CI: 1.11, 1.43). Unmarried/noncohabiting status (OR = 0.91, 95% CI: 0.84, 0.98), maternal smoking (OR = 0.75, 95% CI: 0.67, 0.84), and preterm birth (OR = 0.90, 95% CI: 0.83, 0.98) were associated with reduced risk. Several factors (e.g., older age at first pregnancy, maternal smoking, goiter, benign neoplasms, postpartum hemorrhage, hyperemesis gravidarum, and neonatal jaundice) were associated with advanced thyroid cancer. These findings suggest that some perinatal exposures may influence maternal thyroid cancer risk.

Identifiants

pubmed: 36130211
pii: 6708350
doi: 10.1093/aje/kwac163
pmc: PMC10144719
doi:

Types de publication

Journal Article Research Support, N.I.H., Intramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

70-83

Informations de copyright

Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health 2022. This work is written by (a) US Government employee(s) and is in the public domain in the US.

Références

Int J Cancer. 2015 Mar 1;136(5):1218-27
pubmed: 25041790
Int J Cancer. 2015 Sep 1;137(5):1209-16
pubmed: 25665163
JAMA. 2015 Mar 3;313(9):926-35
pubmed: 25734734
Int J Cancer. 2016 Mar 1;138(5):1085-93
pubmed: 26379007
J Womens Health (Larchmt). 2009 Nov;18(11):1847-56
pubmed: 19951221
J Clin Endocrinol Metab. 2004 Dec;89(12):6077-86
pubmed: 15579761
Cancer Epidemiol Biomarkers Prev. 2014 Jun;23(6):976-85
pubmed: 24646451
Cancer. 2015 Jun 15;121(12):2072-7
pubmed: 25737403
Lancet Diabetes Endocrinol. 2020 Jun;8(6):468-470
pubmed: 32445733
Eur J Endocrinol. 2006 Aug;155(2):219-28
pubmed: 16868134
Thyroid Res. 2015 Jun 18;8:8
pubmed: 26146517
J Clin Endocrinol Metab. 2013 Jul;98(7):2725-33
pubmed: 23744409
Acta Obstet Gynecol Scand. 2014 Feb;93(2):132-7
pubmed: 24237585
J Clin Endocrinol Metab. 2018 Jun 1;103(6):2216-2224
pubmed: 29590402
J Intern Med. 2018 May;283(5):430-445
pubmed: 29476569
Endocrinol Metab Clin North Am. 2019 Sep;48(3):557-567
pubmed: 31345523
Cancer Epidemiol Biomarkers Prev. 2011 Aug;20(8):1751-9
pubmed: 21791618
J Clin Endocrinol Metab. 2012 Aug;97(8):2661-9
pubmed: 22569239
N Engl J Med. 2016 Aug 25;375(8):794-8
pubmed: 27557308
Cancer Epidemiol Biomarkers Prev. 1996 Jun;5(6):425-31
pubmed: 8781737
Acta Oncol. 2018 Apr;57(4):440-455
pubmed: 29226751
J Clin Endocrinol Metab. 1992 Nov;75(5):1333-7
pubmed: 1430095
J Clin Oncol. 2022 Aug 10;40(23):2578-2587
pubmed: 35417260
Lancet Diabetes Endocrinol. 2021 Feb;9(2):94-105
pubmed: 33347809
J Clin Endocrinol Metab. 2017 Dec 1;102(12):4642-4647
pubmed: 29040691
Int J Oncol. 2010 May;36(5):1067-80
pubmed: 20372779
Eur J Epidemiol. 2014 May;29(5):343-51
pubmed: 24848607
Clin Epidemiol. 2021 Jul 19;13:533-554
pubmed: 34321928
Cancer Causes Control. 2012 Oct;23(10):1615-24
pubmed: 22843022
Thyroid. 2017 Mar;27(3):315-389
pubmed: 28056690

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH